Allopurinol Tablet
Product Images NDC 71610-197

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 71610-197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 100 mg (71610 0197 60)

Altogurinal, usp is a medication that comes in a tablet form. The package contains 60 tablets. The medication has a GTIN of 10371610197600 and an N number of 123056780. The expiration date is 2/2020. Not available.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

R:\regulatory\spl\jennifer\allopurinol\allopurinol10032017\allopurinol-01.jpg (Allopurinol 01)

FDA Label Image

R:\regulatory\spl\jennifer\allopurinol\allopurinol10032017\allopurinol-02.jpg (Allopurinol 02)

Allopurinol and Oxipurinol are chemical compounds that are used for medical purposes. Allopurinol has a complex molecular structure with a pyrazolo-pyrazalo ring system and a dipyrimidinone unit, while oxipurinol is a derivative of allopurinol. Both compounds are used in treating medical conditions such as gout and cancer. They work by inhibiting the production of uric acid which is a waste product of the body's metabolism. Uric acid if not excreted properly could lead to the development of gout and kidney stones. The molecular structures of these compounds are related to purines such as hypoxanthine, xanthine, and uric acid.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.